StockTipsArenaBeta

BUY Marksans Pharma Limited — Rajesh Palviya, Axis Securities

BUYMarksans Pharma Limited
Marksans Pharma share price target & all analyst calls

byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Swing (≤2wk))24 Jun 2026via CNBC Awaaz.

Entry₹273Stated
Target₹293
Total upside +7.33% (call closed)
Stop loss₹262-4.03% risk
Exit₹26224 Jun 2026, 3:20 pm
Stop-loss hit-4.03%
Follow Rajesh Palviya for new calls(27% target hit, 179 closed calls)Get alertsWatch MARKSANS for new buy/sell callsGet alertsSee 150 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Oct, 5:22 pm IST
1 supporting0 opposing
Supports the BUY call (1)

2 advisors have active short-term BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·11 Jun · 2w ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Marksans Pharma

All analyst calls on Marksans Pharma

More from Rajesh Palviya, Axis Securities

Every call and its outcome